FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017428509> ?p ?o ?g. }

• W3017428509 endingPage "1231" @default.
• W3017428509 startingPage "1222" @default.
• W3017428509 abstract "Patellofemoral arthroplasty (PFA) is one option for the treatment of isolated patellofemoral osteoarthritis, but there are limited data regarding the procedure and results. Because isolated patellofemoral arthritis is relatively uncommon, available case series generally are small, and even within national registries, sample sizes are limited. Combining data from multiple registries may aid in assessing worldwide PFA usage and survivorship.We combined and compared data from multiple large arthroplasty registries worldwide to ask: (1) What proportion of patients undergoing primary knee arthroplasty have PFA? (2) What are the patient and prosthesis characteristics associated with PFA in common practice, as reflected in registries? (3) What is the survivorship free from revision of PFA and what are the reasons for and types of revisions?Data were provided by eight registries that are members of the International Society of Arthroplasty Registries (ISAR) who agreed to share aggregate data: Australia, New Zealand, Canada, Sweden, Finland, Norway, the Netherlands, and the United States. De-identified data were obtained for PFA performed from either the beginning of year 2000, or the earliest recorded implantation date after that in each individual registry when PFA data collection commenced, up to December 31, 2016. This included patient demographics, implant use, all-cause revision rate (determined by cumulative percent revision [CPR]), and reasons for and type of revision.During the data collection period, 6784 PFAs were performed in the eight countries. PFAs comprised less than 1% of primary knee replacements in all registries. Patient demographics were comparable in all countries. Patients were generally more likely to be women than men, and the mean age ranged from 50 years to 60 years. All registries showed a high rate of revision for PFA. The 5-year CPR for any reason ranged from 8.0% (95% CI 4.5 to 11.5) in Norway to 18.1% (95% CI 15.5 to 20.7) in the Netherlands. The most common reason for revision across all countries was disease progression (42%, 434 of 1034). Most PFAs (83%, 810 of 980) were revised to a TKA.The revision risk of PFA in all registries surveyed was more than three times higher than the reported revision risk of TKA at the same times. The survivorship of PFA is similar to that of the no-longer-used procedure of metal-on-metal conventional hip replacement. Although there may be potential functional benefits from PFA, these findings of consistent and alarmingly high rates of revision should create concern, particularly as this procedure is often used in younger patients.Level III, therapeutic study." @default.
• W3017428509 created "2020-05-01" @default.
• W3017428509 creator A5001768844 @default.
• W3017428509 creator A5003053483 @default.
• W3017428509 creator A5004550809 @default.
• W3017428509 creator A5008112490 @default.
• W3017428509 creator A5027361190 @default.
• W3017428509 creator A5030590484 @default.
• W3017428509 creator A5032257154 @default.
• W3017428509 creator A5044609399 @default.
• W3017428509 creator A5048989280 @default.
• W3017428509 creator A5054120051 @default.
• W3017428509 creator A5070420741 @default.
• W3017428509 creator A5081998419 @default.
• W3017428509 creator A5083688418 @default.
• W3017428509 creator A5089079157 @default.
• W3017428509 date "2020-04-17" @default.
• W3017428509 modified "2023-10-18" @default.
• W3017428509 title "Short-term Revision Risk of Patellofemoral Arthroplasty Is High: An Analysis from Eight Large Arthroplasty Registries" @default.
• W3017428509 cites W1215477841 @default.
• W3017428509 cites W1743458930 @default.
• W3017428509 cites W1964081442 @default.
• W3017428509 cites W1979454274 @default.
• W3017428509 cites W1994476786 @default.
• W3017428509 cites W2006938726 @default.
• W3017428509 cites W2010776710 @default.
• W3017428509 cites W2011919468 @default.
• W3017428509 cites W2029701783 @default.
• W3017428509 cites W2030999232 @default.
• W3017428509 cites W2031263492 @default.
• W3017428509 cites W2044442596 @default.
• W3017428509 cites W2062922340 @default.
• W3017428509 cites W2072919073 @default.
• W3017428509 cites W2075785425 @default.
• W3017428509 cites W2087241560 @default.
• W3017428509 cites W2157901155 @default.
• W3017428509 cites W2287873140 @default.
• W3017428509 cites W2342410729 @default.
• W3017428509 cites W2351957173 @default.
• W3017428509 cites W2404099411 @default.
• W3017428509 cites W2404339163 @default.
• W3017428509 cites W2591382767 @default.
• W3017428509 cites W2743241593 @default.
• W3017428509 cites W2790234006 @default.
• W3017428509 cites W2800599937 @default.
• W3017428509 cites W2802925146 @default.
• W3017428509 cites W2883720879 @default.
• W3017428509 cites W2888843528 @default.
• W3017428509 cites W2890211446 @default.
• W3017428509 cites W2900152096 @default.
• W3017428509 cites W2903777941 @default.
• W3017428509 cites W2903851129 @default.
• W3017428509 cites W2911983325 @default.
• W3017428509 cites W2944951431 @default.
• W3017428509 cites W2946779593 @default.
• W3017428509 cites W2955896281 @default.
• W3017428509 cites W4234378935 @default.
• W3017428509 cites W4235892040 @default.
• W3017428509 doi "https://doi.org/10.1097/corr.0000000000001268" @default.
• W3017428509 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7319370" @default.
• W3017428509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32348089" @default.
• W3017428509 hasPublicationYear "2020" @default.
• W3017428509 type Work @default.
• W3017428509 sameAs 3017428509 @default.
• W3017428509 citedByCount "20" @default.
• W3017428509 countsByYear W30174285092020 @default.
• W3017428509 countsByYear W30174285092021 @default.
• W3017428509 countsByYear W30174285092022 @default.
• W3017428509 countsByYear W30174285092023 @default.
• W3017428509 crossrefType "journal-article" @default.
• W3017428509 hasAuthorship W3017428509A5001768844 @default.
• W3017428509 hasAuthorship W3017428509A5003053483 @default.
• W3017428509 hasAuthorship W3017428509A5004550809 @default.
• W3017428509 hasAuthorship W3017428509A5008112490 @default.
• W3017428509 hasAuthorship W3017428509A5027361190 @default.
• W3017428509 hasAuthorship W3017428509A5030590484 @default.
• W3017428509 hasAuthorship W3017428509A5032257154 @default.
• W3017428509 hasAuthorship W3017428509A5044609399 @default.
• W3017428509 hasAuthorship W3017428509A5048989280 @default.
• W3017428509 hasAuthorship W3017428509A5054120051 @default.
• W3017428509 hasAuthorship W3017428509A5070420741 @default.
• W3017428509 hasAuthorship W3017428509A5081998419 @default.
• W3017428509 hasAuthorship W3017428509A5083688418 @default.
• W3017428509 hasAuthorship W3017428509A5089079157 @default.
• W3017428509 hasBestOaLocation W30174285091 @default.
• W3017428509 hasConcept C141071460 @default.
• W3017428509 hasConcept C142724271 @default.
• W3017428509 hasConcept C144024400 @default.
• W3017428509 hasConcept C149923435 @default.
• W3017428509 hasConcept C172400760 @default.
• W3017428509 hasConcept C1862650 @default.
• W3017428509 hasConcept C204787440 @default.
• W3017428509 hasConcept C2776164576 @default.
• W3017428509 hasConcept C2778336525 @default.
• W3017428509 hasConcept C2778715743 @default.
• W3017428509 hasConcept C2780084366 @default.
• W3017428509 hasConcept C2908647359 @default.
• W3017428509 hasConcept C43893838 @default.

• next